Development of generics: From R and D to GMP MasterClass on July 28-29, 2020 in Budapest, Hungary

The interface between Development and GMP units is one of the most exciting in the pharmaceutical industry. R&D needs flexibility and should not be over-regulated, whereas GMP concentrates on standardization and high throughput. On the other hand, R&D has to create a solid and robust fundament to enable manufacturing and quality control to work according to established and efficient procedures. The training aims to generate a common understanding of how to best interlink these two areas and create highly efficient processes from product development to routine manufacturing of generic pharmaceutical products.